24 Results for "

Tumor Homing Peptide

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "Tumor Homing Peptide" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P2526
CAS No.: 454487-07-1
Target:  

Complement System

Research Areas:  

Cancer

LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2526A
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

LyP-1 TFA is a cyclic 9 amino acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-P4089
CAS No.: 945245-82-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

REA is a homing peptide that targets pre-cancerous tumor lymphatic vessels. REA homes to lymphatic vessels at the pre-cancerous tumor stage, but does not recognize tumor lymphatic vessels. REA can be used in pre-cancerous tumor research .
loading...
    loading...
Cat. No.: HY-P10894
CAS No.: 2283322-63-2
Research Areas:  

Cancer

mUNO is a tumor-homing peptide (mUNO, sequence: "CSPGAK") that specifically binds to mouse CD206, targeting tumor-associated macrophages that express CD206/MRC1. mUNO can interact with human recombinant CD206 .
loading...
    loading...
Cat. No.: HY-172271
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG1000-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10) is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-P10997
CAS No.: 536971-53-6
Target:  

DNA/RNA Synthesis

F3 peptide is a nucleolin-binding tumor-homing peptide that mediates selective uptake and internalization by tumor cells. F3 peptide is a 31-amino acid fragment of human high mobility group nucleosomal protein 2 (HMGN2). F3 peptide inhibits protein synthesis through ribosome inactivation. F3 peptide targets the tumor vasculature. F3 peptide can serve as an effective ligand to improve the druggability of macromolecular drugs or nanoparticles. F3 peptide is used in research on cancers such as glioblastoma and breast cancer .
loading...
    loading...
Cat. No.: HY-172271A
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG2000-LyP-1 is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-172271B
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG3000-LyP-1 is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-P11415
CAS No.: 1189359-89-4
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

GX1 is a tumor-homing peptide, and its amino acid sequence is CGNSNPKSC. GX1 can specifically target the vascular endothelial cells of gastric cancer and can be used as a specific imaging probe for gastric cancer angiogenesis .
loading...
    loading...
Cat. No.: HY-P10997A
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease Cancer

F3 peptide acetate is a nucleolin-binding tumor-homing peptide that mediates selective uptake and internalization by tumor cells. F3 peptide acetate is a 31-amino acid fragment of human high mobility group nucleosomal protein 2 (HMGN2). F3 peptide acetate inhibits protein synthesis through ribosome inactivation. F3 peptide acetate targets the tumor vasculature. F3 peptide acetate can serve as an effective ligand to improve the druggability of macromolecular drugs or nanoparticles. F3 peptide acetate is used in research on cancers such as glioblastoma and breast cancer .
loading...
    loading...
Cat. No.: HY-187402A
Research Areas:  

Cancer

DOPE-PEG2000-CSTSMLKAC is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the CSTSMLKAC peptide, a cyclic tumor-homing peptide with a disulfide bond formed by flanking cysteine residues. DOPE-PEG2000-CSTSMLKAC is used for tumor-targeted drug delivery through liposome and nanoparticle surface modification.
loading...
    loading...
Cat. No.: HY-187410A
Synonyms: DOPE-PEG2000-Mal-Cys-APRPG
Research Areas:  

Cancer

DOPE-PEG2000-APRPG (DOPE-PEG2000-Mal-Cys-APRPG) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the APRPG peptide (Ala-Pro-Arg-Gly), a tumor-homing peptide. DOPE-PEG2000-APRPG is used for tumor vasculature-targeted drug delivery.
loading...
    loading...
Cat. No.: HY-187416A
Synonyms: DOPE-PEG2000-Mal-Cys-CGKRK
Research Areas:  

Cancer

DOPE-PEG2000-CGKRK (DOPE-PEG2000-Mal-Cys-CGKRK) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the CGKRK peptide, a tumor-homing peptide identified by in vivo phage display. DOPE-PEG2000-CGKRK is used for tumor-targeted drug delivery through liposome and nanoparticle surface modification.
loading...
    loading...
Cat. No.: HY-187490A
Synonyms: DOPE-PEG2000-Mal-Cys-CREKA
Research Areas:  

Cancer

DOPE-PEG2000-CREKA (DOPE-PEG2000-Mal-Cys-CREKA) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the CREKA peptide (Cys-Arg-Glu-Lys-Ala), a tumor-homing peptide identified by in vivo phage display. DOPE-PEG2000-CREKA is used for tumor stroma-targeted drug delivery.
loading...
    loading...
Cat. No.: HY-187474A
Synonyms: DOPE-PEG2000-Mal-Cys-HTMYYHHYQHHL
Research Areas:  

Cancer

DOPE-PEG2000-K237 (DOPE-PEG2000-Mal-Cys-HTMYYHHYQHHL) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the K237 peptide (sequence: HTMYYHHYQHHL). K237 peptide is a tumor-homing peptide identified by phage display that specifically binds to vasculature in tumor tissues. DOPE-PEG2000-K237 is used for tumor-targeted drug delivery via functionalization of liposomes and nanoparticles.
loading...
    loading...
Cat. No.: HY-P10989
CAS No.: 241478-23-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

NG2 binding peptide is a short peptide that specifically recognizes NG2 proteoglycan and can be obtained by phage screening technology. NG2 binding peptide interacts with NG2 binding sites to achieve precise targeting of tumor angiogenesis in vitro and in vivo. NG2 binding peptide exhibits significant homing ability in wild-type tumor-bearing mice, but has no localization effect in NG2 knockout mice. Due to the tissue specificity of NG2 expression, NG2 binding peptide can be used in scenarios such as tumor targeted therapy, drug delivery, and molecular imaging diagnosis .
loading...
    loading...
Cat. No.: HY-187399A
Synonyms: DOPE-PEG2000-Mal-Cys-NGR
Research Areas:  

Cancer

DOPE-PEG2000-NGR (DOPE-PEG2000-Mal-Cys-NGR) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the NGR (Asn-Gly-Arg) peptide, a tumor-homing tripeptide motif. NGR peptide specifically binds to aminopeptidase N (CD13) that is overexpressed on angiogenic tumor vasculature. DOPE-PEG2000-NGR is used for tumor vasculature-targeted drug delivery and anti-angiogenic research.
loading...
    loading...
Cat. No.: HY-P11815
CAS No.: 1227627-77-1
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

TMTP1 is a five-amino acid (NVVRQ) tumor-homing peptide. TMTP1 slows the growth of tumor cells. TMTP1 serves as a diagnostic marker for hematological malignancies and acts as an anticancer drug carrier to enhance the cellular uptake rate of nanocarriers in tumor tissues. TMTP1 is applicable to research related to hematological malignancies, lymphoma, chronic myeloid leukemia, cervical cancer, and ovarian cancer .
loading...
    loading...
Cat. No.: HY-181742
Target:  

ULK PI3K Autophagy

Research Areas:  

Cancer

ULK1/2-IN-1 is a tissue-targeted ULK1/2 inhibitor conjugated to the RGR (CRGRRST) tumor neovasculature-homing peptide. ULK1/2-IN-1 mediates autophagy inhibition and induces cytotoxicity in endothelial cells. ULK1/2-IN-1 can be used for the research of tumor-targeted autophagy inhibitors .
loading...
    loading...
Cat. No.: HY-187401A
Synonyms: DOPE-PEG2000-Mal-Cys-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK
Research Areas:  

Cancer

DOPE-PEG2000-F3 (DOPE-PEG2000-Mal-Cys-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the F3 peptide, a tumor-homing peptide derived from the high-mobility group protein N2 (HMGN2). DOPE-PEG2000-F3 is used for tumor-targeted drug delivery.
loading...
    loading...